Member Login
  1. Stocks
    2. /
  2. Indivior PLC (LSE: INDV)
    3. /

LSE:INDV (Indivior PLC)

About INDV

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Indivior PLC (LSE: INDV) Latest News

    Investing Articles

    Big Director Buys At Diageo plc, BG Group plc And Indivior PLC

    | G A Chester

    Directors have been splashing the cash at Diageo plc (LON:DGE), BG Group plc (LON:BG) and Indivior PLC (LON:INDV).

    Read more »

    Investing Articles

    Is Indivior PLC The Perfect Partner For AstraZeneca plc In Your Portfolio?

    | Peter Stephens

    Could now be the right time to add both Indivior PLC (LON: INDV) and AstraZeneca plc (LON: AZN) to your…

    Read more »

    Investing Articles

    Why I’ve Bought Reckitt Benckiser Group plc’s Spin-Off, Indivior PLC

    | Rupert Hargreaves

    Reckitt Benckiser Group Plc's (LON: RB) spin-off Indivior PLC (LON: INDV) looks to be undervalued.

    Read more »

    Investing Articles

    Should You Buy, Sell, Or Hold Reckitt Benckiser Group Plc’s Spinoff, Indivior PLC?

    | Rupert Hargreaves

    Should you buy, sell, or hold Reckitt Benckiser Group Plc's (LON: RB) spinoff, Indivior PLC (LON: INDV)?

    Read more »